Has Alexander Perino, MD received payments from drug or device companies?

Yes. Drug and device makers reported $85,496 in general payments to Alexander Perino, MD across 326 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alexander Perino, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alexander Perino, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alexander Perino, MD

Clinical Cardiac Electrophysiology · Stanford, CANPI 1639435100

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Abbott at 31.1% of the total. 2025 is the largest year on record at $31,912, 7.3 times the $4,382 reported in 2019.

$85,496in general payments, 2019–2025

Across 326 payments — averaging $262.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$27K
Biosense Webster, Inc.$25K
Boston Scientific$11K
Medical Device Business Services, Inc.$9K
E.r. Squibb & Sons, L.L.C.$5K
Biotronik Inc.$4K
plus $5K from 8 others

$287,408in research payments, 2019–2025

Across 41 payments — averaging $7009.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$146K
Abbott$135K
Medtronic$6K

What the payments were for

Consulting fees$32,51038%
Speaking & faculty fees$21,11925%
Grants$5881%
Travel & lodging$16,85320%
Food & beverage$14,42717%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	136	$26,563
Biosense Webster, Inc.	75	$24,572
Boston Scientific	36	$10,977
Medical Device Business Services, Inc.	17	$8,746
E.r. Squibb & Sons, L.L.C.	2	$5,200
Biotronik Inc.	21	$4,447
Medtronic(2 entities)	25	$3,007
Cardiva Medical, Inc.	3	$1,007
EBR Systems, Inc.	4	$633
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$173
Janssen Scientific Affairs, LLC	1	$81
Irhythm Technologies, Inc.	1	$38
Acist Medical Systems, Inc.	1	$33
Edwards Lifesciences	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$85,496 in reported general payments places this provider in the 75th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024

$394,956

Medicare patients

1,101

Services billed

2,631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	195	$257,133
XareltoRivaroxaban	38	$43,754
Flecainide Acetate	36	$2,389
Metoprolol Succinate	89	$1,106
SotalolSotalol Hcl	32	$778
Sucralfate	69	$742
Amiodarone Hcl	18	$625
Pantoprazole Sodium	90	$452
Metoprolol Tartrate	26	$368

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Stanford

Sanjiv NarayanStanford$357K
Marco PerezStanford$204K
Tina BaykanerStanford$168K
Nitish BadhwarStanford$154K
Girish NarayanStanford$117K
Minang TurakhiaStanford$110K
Shephal DoshiSanta Monica$2.1M
Jonathan HsuSan Diego$1.2M
Leslie SaxonLos Angeles$1.1M
Rahul BhardwajLoma Linda$935K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →